---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-24-000006"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:26:55.706770+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho widens FY2024 adjusted diluted EPS range to $1.88-$3.60; midpoint unchanged

## Summary
- Corrected FY2024 adj. diluted EPS guidance: $1.88-$3.60 (midpoint $2.74 unchanged); previously narrower range.
- Total revenue guidance unchanged at $2.76-$3.07B; non-respiratory $2.30-$2.34B; respiratory $460-$730M.
- Adjusted EBITDA guidance unchanged at $565-$720M (21-24% margin).
- Correction filed Feb 16 after initial Feb 13 earnings release and guidance.

## SEC filing metadata
- accession: 0001906324-24-000006
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000006/0001906324-24-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000006/qdel-20240216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-24-000006
- JSON: https://secwatch.observer/filing/0001906324-24-000006.json
- Plain text: https://secwatch.observer/filing/0001906324-24-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.